Patent ID: 9551768
Date: 2017-01-24
CPC Classifications: A61B,G01N,G01R,G16H

Claim:
1. A method for assessing cardiovascular disease risk based upon the properties of protein and lipoprotein elements in a sample, the method comprising the steps of: conducting a low-speed centrifugation of a human blood sample obtained after clotting; placing a small volume of the unfractionated human serum sample into a low field TD-NMR spectrometer tuned to measure hydrogen-1; applying a series of CPMG spin echo pulse sequences with intermittent delays to the sample in order to measure spin-spin relaxation time constants from the time-domain decay of the signal, without the use of chemical shifts and without converting data into the frequency domain by Fourier transform or other means; at least partially suppressing the water signal from the sample by inserting a 180-degree inversion pulse followed by a delay prior to the CMPG sequence used to record relaxation time constants in the time domain; analyzing the exponentially decaying NMR signal from the sample in the time domain using multi-exponential analysis; and comparing differences in the relaxation time constants for lipoprotein classes selected from the group consisting of LDL, HDL, and VLDL in the sample to measure mobility differences in the oil phases within the core compartment of the selected lipoprotein particles which are in turn reflective of increased cardiovascular disease risk or active disease and in which the comparison of relaxation time constants is made to other relaxation time constants within a group consisting of samples from the same human subject and samples among different human subjects.